Global private equity and venture capital news and research

Posts Tagged ‘Genstar Capital’

21 July 2014

Blackstone-backed healthcare company Catalent targets up to $935m in New York IPO

medicals-962561-m Private equity giant Blackstone is set to retain its majority holding in healthcare and drug company Catalent when its floats on the New York Stock Exchange later this year.

23 June 2014

Genstar to buy Asset International a week after selling health payments company Evolution1

dollar money capital fund Genstar Capital has signed a definitive agreement to buy Asset International from fellow mid-market buyout house Austin Ventures.

17 June 2014

Genstar Capital exits Evolution1 in $532.5m deal

wexx Mid-market firm Genstar Capital has exited its investment in consumer directed health payments specialist Evolution1, which was sold to Wex for $532.5m.

16 June 2014

Genstar Capital appoints ex-Surescripts CEO to strategic advisory board

totonis Mid-market firm Genstar Capital has added former president and CEO of clinical information exchange network Surescripts Harry Totonis to its strategic advisory board.

12 May 2014

Genstar Capital completes TravelClick exit in $930m Thoma Bravo buyout

travelodge-3_sq.jpg Mid-market US private equity firm Genstar Capital has completed the sale of portfolio company TravelClick to Thoma Bravo in a deal worth $930m.

20 March 2014

Genstar, Bain Capital Ventures seal 3.8x return through $930m TravelClick sale

forest holidays_sq Genstar Capital and Bain Capital Ventures have reportedly netted a 3.8-times return on their investment in software group TravelClick through the $930m sale to Thoma Bravo.

28 January 2014

Genstar Capital eyes TravelClick exit

hotel2_lrg Private equity firm Genstar Capital is reportedly considering exiting its investment in hotel booking software company TravelClick.

27 January 2014

Genstar Capital commits to earthquake insurance provider Palomar

earthquake Mid-market private equity investor Genstar Capital has reportedly led a $75m equity investment in earthquake insurance business Palomar Specialty Insurance.

24 June 2013

Genstar exits PRA to KKR for $1.3bn

O Mid-market private equity firm Genstar Capital has sold contract research organization PRA to buyout major KKR after six years of ownership.

5 June 2013

KKR, Warburg, Cinven mull bids for clinical research group PRA

biotech_lrg Buyout majors KKR, Warburg Pincus and Cinven are reportedly mulling offers for clinical research group PRA International, which current owner Genstar Capital hopes to sell for $1.3bn.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014